BREO ELLIPTA 100-25 MCG INHALR

fluticasone furoate and vilanterol trifenatate
$5.3663per EA

Strength

100; 25 ug/1; ug/1

NDC

00173085914

Classification

Brand

Dosage Form

POWDER

Route

RESPIRATORY (INHALATION)

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA204275

On Market Since

8/26/2013

Pharmacological Classes

Adrenergic beta2-Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
beta2-Adrenergic Agonist

Price History

1W

0.0%

1M

+0.0%

3M

-0.2%

6M

-0.2%

1Y

-0.1%

3Y

+2.4%

5Y

+8.6%

All

+51.8%